| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,515,507 | 1,210,580 | 1,044,914 | 343,540 | | Cost of Revenue | 801,548 | 450,075 | 203,378 | 350,480 | | | Gross Profit | 712,960 | 760,505 | 841,536 | (6,941) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (264,815) | 307,532 | 324,284 | 41,765 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 387,559 | 383,955 | 327,486 | 603,514 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,279,785) | 69,019 | 189,766 | (652,219) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 386,216 | 69,019 | 189,766 | (652,219) | | Interest Expense | 88,099 | 68,453 | 54,448 | 20,068 | | Income Before Tax | 298,117 | 565 | 135,318 | (672,287) | | Income Tax Expense | 114,076 | (17,898) | 24,822 | (190,159) | | Minority Interest | (11,673) | (1,925) | (2,402) | 6,164 | | | | Net Income From Continuing Ops | 172,368 | 16,538 | 108,095 | (475,964) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 172,368 | 16,538 | 108,095 | (475,964) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $172,368 | $16,538 | $108,095 | ($475,964) |
|
0.16% Nasdaq 
Income Statement
